CANCER
Technologies Available for License
Method of
Detecting and
Grading Dysplasia in Epithelial Tissue..........................001-97
A Method of
Therapeutic Intervention
To Enhance T Cell Immunity By Promoting
De Novo Production of Antigen Specific
Lymphocytes Using Synthetic Ligands.........................004-01
U.S. Patent Application 20030021796
Method For Treating Prostate Cancer..........................012-01
U.S. Patent Application 20020115613
Antigen-Presenting
Cell Populations and LICENSED
Their Use as Reagents for Enhancing or
Reducing ImmuneTolerance..........................................011-02
U.S. Patent Application 20030194803
PCT Application Filed
Compositions and Methods for the
Intracellular Disruption of VEGF and KDR
by RNA Interference and Intraceptors..........................013-04
U.S. Patent Pending
PLD Inhibitor for Production of
Regulatory
T Cells and Tolerogenic Vaccine.....................014-04, 021-04
U.S. Patent Pending